Agilon Health, Inc. · NYSE:AGL
Agilon Health — Q1 2025 Earnings Presentation
10 slides from Agilon Health's earnings presentation, May 6, 2025
Slide 1: First Quarter 2025 Earnings Results
First Quarter 2025 Earnings Results 5.6.2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Slide 2: Disclaimers and Forward-Looking Statements
Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Slide 3: Key Takeaways
Key Takeaways Strengthening the business for long-term success Strategic actions combined with cost discipline to help drive near-term improvement and sustainable long- term profitability Disciplined growth balancing near-term market challenges and optimizing long-term opportunity Investing in advan
Slide 4: Strengthening the business for long-term success
Strengthening the business for long-term success Strategic actions combined with cost discipline supports sustainable long-term profitability • Reduced exposure to Part D to less than 30% of membership • Maintain flat YoY G&A expense including platform support cost Disciplined growth- addressing cur
Slide 5: Q1 2025 Financial Performance
Q1 2025 Financial Performance Quarter Ending March 31, 2025 Medicare Advantage Members 491,000 ACO Model Members 114,000 Total Members Live on Platform 605,000 Avg. Medicare Advantage Members 490,000 Total Revenues ($M) $1,533 Gross Profit ($M) $51 Medical Margin ($M) $128 Net Income (Loss) ($M) $12
Slide 6: 2025 Financial Outlook
2025 Financial Outlook Quarter Ending Year Ending June 30, 2025 December 31, 2025 Medicare Advantage Members 485,000 – 515,000 490,000 – 520,000 ACO Model Members 105,000 – 115,000 105,000 – 115,000 Total Members Live on Platform 590,000 – 630,000 595,000 – 635,000 Avg. Medicare Advantage Members 49
Slide 7: Strong Balance Sheet To Support Growth
Strong Balance Sheet To Support Growth Capital light model, stabilization in MA and strategic initiatives expected to deliver break-even cashflow in 2027 Balance Sheet & Cash Flow ~$394M of cash ( Q1 2025)1 Anticipate '25 Cash Burn of Expected to achieve break-even ~$110M cash flow in 2027 Capital D
Slide 8: Appendix
Appendix Copyright © 2024 agilon health 8
Slide 9: Non-GAAP Reconciliations
Non-GAAP Reconciliations Medical Margin (Dollars in thousands) Three Months Ended March 31, 2025 Gross profit(1) $ 50,722 Other operating revenue (2,903) Other medical expenses 80,193 Medical margin $ 128,012 1) Gross profit is defined as total revenues less medical services expenses and other medic
Slide 10: Non-GAAP Reconciliations
Non-GAAP Reconciliations Adjusted EBITDA (Dollars in thousands) Three Months Ended March 31, 2025 Net income (loss)(1) $ 12,112 (Income) loss from discontinued operations, net of income taxes (14,000) Interest expense 1,515 Income tax expense (benefit) 196 Depreciation and amortization 6,876 Severan